Milestone Pharmaceuticals Inc. (MIST): Price and Financial Metrics


Milestone Pharmaceuticals Inc. (MIST): $5.57

-0.08 (-1.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MIST Stock Price Chart Interactive Chart >

Price chart for MIST

MIST Price/Volume Stats

Current price $5.57 52-week high $9.03
Prev. close $5.65 52-week low $5.09
Day low $5.54 Volume 3,618
Day high $5.65 Avg. volume 67,518
50-day MA $5.67 Dividend yield N/A
200-day MA $6.25 Market Cap 166.24M

Milestone Pharmaceuticals Inc. (MIST) Company Bio


Milestone Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. It designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada.


MIST Latest News Stream


Event/Time News Detail
Loading, please wait...

MIST Latest Social Stream


Loading social stream, please wait...

View Full MIST Social Stream

Latest MIST News From Around the Web

Below are the latest news stories about Milestone Pharmaceuticals Inc that investors may wish to consider to help them evaluate MIST as an investment opportunity.

Milestone Pharmaceuticals to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Amit Hasija, Chief Financial Officer and Executive Vice President of Corporate Development, will present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference on Wednesday, September 29, 2021 at 10:00 a.m. ET. The conference will be held in a virtual meeting format.

Yahoo | September 22, 2021

Milestone Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually on September 13-15, 2021.

Yahoo | September 7, 2021

What Kind Of Shareholders Own Milestone Pharmaceuticals Inc. (NASDAQ:MIST)?

If you want to know who really controls Milestone Pharmaceuticals Inc. ( NASDAQ:MIST ), then you'll have to look at the...

Yahoo | August 16, 2021

Milestone Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Update

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the second quarter ended June 30, 2021 and provided a clinical and corporate update.

Yahoo | August 11, 2021

10 Stocks to Buy According to Neil Shahrestani’s Ikarian Capital

In this article, we will take a look at the 10 stocks to buy according to Neil Shahrestani’s Ikarian Capital. To skip our detailed analysis of Shahrestani’s history, hedge fund performance, and investment philosophy, go directly to the 5 Stocks to Buy According to Neil Shahrestani’s Ikarian Capital. Neil Shahrestani, MD, is the Chief Investment Officer, managing […]

Yahoo | August 3, 2021

Read More 'MIST' Stories Here

MIST Price Returns

1-mo -11.45%
3-mo 1.27%
6-mo -7.93%
1-year -25.83%
3-year N/A
5-year N/A
YTD -16.87%
2020 -58.15%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8565 seconds.